Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Hepatitis CLiver Transplantation
Interventions
DRUG

cyclosporin (Neoral)

Neoral capsules bid, Doses were to be adjusted as necessary to achieve and maintain recommended C0 (monitoring of trough levels) or C2 concentration 2 hours post dosing) target ranges

DRUG

tacrolimus (Prograf)

Tacrolimus capsules bid, doses were adjusted as necessary to achieve and maintain recommended C0 target ranges.

Trial Locations (45)

1070

Novartis Investigative Site, Brussels

8091

Novartis Investigative Site, Zurich

15706

Novartis Investigative Site, Santiago de Compostela

20246

Novartis Investigative Site, Hamburg

31054

Novartis Investigative Site, Toulouse

32610

Novartis Investigative Site, Gainesville

33006

Novartis Investigative Site, Oviedo

33100

Novartis Investigative Site, Udine

34295

Novartis Investigative Site, Montpellier

35128

Novartis Investigative Site, Padua

40138

Novartis Investigative Site, Bologna

47012

Novartis Investigative Site, Valladolid

53792

Novartis Investigative Site, Madison

55131

Novartis Investigative Site, Mainz

60590

Novartis Investigative Site, Frankfurt

69317

Novartis Investigative Site, Lyon

73112

Novartis Investigative Site, Oklahoma City

75012

Novartis Investigative Site, Paris

77030

Novartis Investigative Site, Houston

81377

Novartis Investigative Site, München

85054

Novartis Investigative Site, Phoenix

94000

Novartis Investigative Site, Créteil

94800

Novartis Investigative Site, Villejuif

95128

Novartis Investigative Site, Palo Alto

110111

Novartis Investigative Site, Bogotá

123182

Novartis Investigative Site, Moscow

129010

Novartis Investigative Site, Moscow

94143-2205

Novartis Investigative Site, San Francisco

27599-7211

Novartis Investigative Site, Chapel Hill

77030-2400

Novartis Investigative Site, Houston

60430-270

Novartis Investigative Site, Fortaleza

04023-900

Novartis Investigative Site, São Paulo

T6G 2B7

Novartis Investigative Site, Edmonton

V5Z 1M9

Novartis Investigative Site, Vancouver

R3E 0W3

Novartis Investigative Site, Winnipeg

N6A 4G5

Novartis Investigative Site, London

M5G 2C4

Novartis Investigative Site, Toronto

Unknown

Novartis Investigative Site, Bogotá

110 744

Novartis Investigative Site, Seoul

120-752

Novartis Investigative Site, Seoul

135-710

Novartis Investigative Site, Seoul

137-701

Novartis Investigative Site, Seoul

08035

Novartis Investigative Site, Barcelona

08036

Novartis Investigative Site, Barcelona

B15 2TT

Novartis Investigative Site, Birmingham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY